Randomized, Balanced, Single Dose, Cross-Over Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2015
At a glance
- Drugs CHF 5074 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Acronyms CT03
- Sponsors Chiesi
- 14 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Feb 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.